Health Condition 1: F510- Insomnia not due to a substance orknown physiological condition
Conditions
Interventions
None listed
Sponsors
Dr Rushikesh Dilip Chalak
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patient with classical sign & symptoms of Anidra 2.Patient who are fulfilling the American Psychiatric Association (DSM-IV) diagnostic criteria of Primary Insomnia. 3.Patient with On-going medication of other systemic disorders which does not interfere with the current course of insomnia will be included in the study.
Exclusion criteria
Exclusion criteria: 1. Patient with Secondary Insomnia. 2.Patient with Alcohol dependency. 3.Patient suffering with major psychiatric disorders and other Systemic disorders. 4.Patient on Hypnotic medications, sedative drugs or any other drugs which causes drowsiness. 5.Patient with Lactose intolerance. 6.Pregnant and lactating women will be excluded. 7.Patient denying consent.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effect of trail drug over anidra (primary insomnia) is assessed by the Pittsburgh Sleep Quality index and Patients mental statusTimepoint: 15day, 30 day, 45 day | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety of trial drug & adverse drug reaction, aggravation of the symptoms of the symptoms of Anidra (Primary Insomnia).Timepoint: 15day 30day 45day | — |
Countries
India
Contacts
Public ContactDr Rushikesh Dilip Chalak
Sidramappa Danigond Memorial Trusts Ayurvedic Medical College Post Graduation Centre
Outcome results
None listed